Ningbo Menovo Pharm Co Ltd
Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. The company's products portfolio includes valsartan, losartan, clopidogrel, perindopril, rosuvastatin calcium, atorvastatin calcium, purin bahrain, and other products. It offers APIs, intermediates, and preparations for the treatment of cardiovascular, central nervous system, gastrointestinal t… Read more
Ningbo Menovo Pharm Co Ltd (603538) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.016x
Based on the latest financial reports, Ningbo Menovo Pharm Co Ltd (603538) has a cash flow conversion efficiency ratio of 0.016x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥38.86 Million) by net assets (CN¥2.42 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ningbo Menovo Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Ningbo Menovo Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Ningbo Menovo Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ningbo Menovo Pharm Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sarkuysan Elektrolitik Bakir Sanayi ve Ticaret AS
IS:SARKY
|
-0.017x |
|
Shenzhen Urovo Technology Co Ltd
SHE:300531
|
0.058x |
|
Heiwa Corporation
F:HWC
|
0.024x |
|
Kimball Electronics
NASDAQ:KE
|
0.012x |
|
Metropolis Healthcare Limited
NSE:METROPOLIS
|
0.091x |
|
Genesis Energy Limited
F:1G6
|
N/A |
|
Advanced Wireless Semiconductor Co
TWO:8086
|
0.035x |
|
Argan SA
PA:ARG
|
0.047x |
Annual Cash Flow Conversion Efficiency for Ningbo Menovo Pharm Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Ningbo Menovo Pharm Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.29 Billion | CN¥97.54 Million | 0.043x | +918.66% |
| 2023-12-31 | CN¥2.19 Billion | CN¥9.13 Million | 0.004x | -96.72% |
| 2022-12-31 | CN¥2.17 Billion | CN¥276.95 Million | 0.127x | +14.28% |
| 2021-12-31 | CN¥1.98 Billion | CN¥220.63 Million | 0.112x | -21.89% |
| 2020-12-31 | CN¥1.76 Billion | CN¥251.61 Million | 0.143x | +24.57% |
| 2019-12-31 | CN¥1.57 Billion | CN¥179.75 Million | 0.115x | +229.61% |
| 2018-12-31 | CN¥1.34 Billion | CN¥46.60 Million | 0.035x | -49.57% |
| 2017-12-31 | CN¥1.16 Billion | CN¥80.15 Million | 0.069x | -57.01% |
| 2016-12-31 | CN¥731.02 Million | CN¥117.24 Million | 0.160x | -22.37% |
| 2015-12-31 | CN¥645.81 Million | CN¥133.42 Million | 0.207x | +55.00% |
| 2014-12-31 | CN¥564.34 Million | CN¥75.22 Million | 0.133x | -56.46% |
| 2013-12-31 | CN¥487.44 Million | CN¥149.21 Million | 0.306x | +255.52% |
| 2012-12-31 | CN¥442.58 Million | CN¥38.11 Million | 0.086x | -73.22% |
| 2011-12-31 | CN¥378.47 Million | CN¥121.67 Million | 0.321x | -- |